Loading…
← CockpitCompetitor Analysis › 301580.SZ Aidite (Qinhuangdao) Technology Co., Ltd. Class AOpen in the cockpit ↗

Aidite (Qinhuangdao) Technology Co., Ltd. Class A301580.SZCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical Specialties

Chinese maker of zirconia and other ceramic dental-restoration materials for CAD/CAM dental labs.

≈ A Chinese Ivoclar/3M dental-ceramics supplierMomentum neutral 55
Mkt cap
$888M
US dollars, full cap
Free float
76%
of shares outstanding
$/day
$32.1M
20-day average traded
Fwd P/E
26.2×
forward earnings
ROIC−WACC
+7.9 pp
WACC 11.5%
Hurdle
-4 pp
Req g minus delivered
Next earnings
168 days
5 May 2027
Close · CNYCN¥39.94
1D+0.3%
1W-4.6%
1M-8.4%
3M-24.1%
6M-11.7%
YTD+26.5%
1Y+23.9%
ATR %6.5%
52w lowhigh54.6% off high

What Aidite (Qinhuangdao) Technology does

Chinese maker of zirconia and other ceramic dental-restoration materials for CAD/CAM dental labs.

Zirconia blocks are consumables milled into crowns and bridges, so sales recur with the number of restorations. The shift of dental labs from hand-made to digitally milled work expands the market for such blocks.

In one line: A Chinese Ivoclar/3M dental-ceramics supplier.

Products and services

  • Zirconia dental blocks
  • Dental ceramics/porcelain
  • CAD/CAM dental materials

Customers

  • Dental laboratories
  • Dentists

Where it sits in the supply chain

  • Health Care
  • Dental materials
  • Zirconia/ceramic dental restoration…

What could go right

  • Dental restoration/CAD-CAM adoption growth

What could go wrong

  • Dental-material price competition

Moat: narrow (process know-how, brand). Ceramic material formulation know-how differentiates strength/aesthetics for dental labs.

Headquarters: Qinhuangdao, Hebei, China · Employees: 1,303

Named competitors

Aidite (Qinhuangdao) Technology at a glance

Size Aidite (Qinhuangdao) Technology (301580.SZ) is a China Health Care company (Medical Specialties) with a market value of $888M, the 2387th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥39.94 on 18 Nov 2026.

Performance Over six months the shares fell 11.7%, against -13.6% for the median peer and -20.0% for the China market (cap-weighted) — 9th highest of 21 in its peer set.

Growth Revenue grew 16.5% over the last twelve months (peer median +6.0%); the operating margin is 17.8% (peer median 9.0%).

Valuation It trades at 26.2× forward earnings against a peer median of 20.9× (7th most expensive of 16).

Price implies For today's price to make sense, revenue must grow about 19% a year for seven years (Req g). Recent delivered growth is +23%, so the hurdle is -4 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 7.9 points above its cost of capital (11.5% WACC).

Next results Next results expected around 5 May 2027 (exchange calendar; dates can move).

Relative performance

10015021 May 202621 Aug 202618 Nov 2026301580.SZ 89Peer median 87
Six months, rebased to 100: Aidite (Qinhuangdao) Technology against the median of its 20 peers (local-currency closes).

Aidite (Qinhuangdao) Technology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.16BCN¥1.03BCN¥884MCN¥774MCN¥601M
Revenue growth—+16%+14%+29%—
Gross profitCN¥628MCN¥503MCN¥441MCN¥367MCN¥265M
EBITDAn/aCN¥212MCN¥190MCN¥157MCN¥108M
Net incomeCN¥202MCN¥196MCN¥150MCN¥147MCN¥116M
Free cash flowCN¥114MCN¥219MCN¥68.1MCN¥118MCN¥179M
Capital expenditureCN¥123MCN¥68.8MCN¥84.4MCN¥33.2MCN¥44.5M
Total debtCN¥29.3MCN¥28.7MCN¥7.06MCN¥1.40MCN¥44.3M

Quarterly statements and history in the cockpit →

Aidite (Qinhuangdao) Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%+40%-20%0%688575BVS688767688626AORT688277KURN00265868865630160236006033672906507780SFLKIDS30467730301580.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Aidite (Qinhuangdao) Technology is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%0×200×400×688575BVS688767688626AORTKURN002658688656360060336711877780SFL3046301580.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Aidite (Qinhuangdao) Technology is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%688575BVS00265868865630160236006033672906501187SFL7730301580.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Aidite (Qinhuangdao) Technology is the large dot.

Aidite (Qinhuangdao) Technology competitors and peer comparison

Head to head with its named competitors (301580.SZ vs MMM vs XRAY)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Aidite (Qinhuangdao) Technology 301580.SZ$888M-12%+17%18%26.2×19.3%
3M MMM$93.6B+22%+2%21%18.8×11.3%
DENTSPLY SIRONA XRAY$1.69B-13%-1%5%6.8×11.2%

How Aidite (Qinhuangdao) Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Aidite (Qinhuangdao) Technology against its 20 peers (data as of 18 Nov 2026)
Measure301580.SZPeer medianRank in peer set
1-month return-8.4%-5.1%9th lowest of 21
6-month return-11.7%-13.6%9th highest of 21
Distance from 52-week high-54.6%-40.0%6th lowest of 21
Revenue growth (TTM)+16.5%+6.0%5th highest of 21
Operating margin17.8%9.0%5th highest of 21
Forward P/E26.2×20.9×7th most expensive of 16
Growth the price implies (Req g, 7 yrs)19.3%3.3%4th most demanding of 14
Growth delivered (Del g)+23.3%+11.7%highest of 14
Hurdle (Req g minus delivered)-4.0 pp-4.6 pp7th most demanding of 14
ROIC minus cost of capital+7.9 pp+2.0 pp5th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Aidite (Qinhuangdao) Technology 301580.SZChina$888M-12%+17%18%26.2×19.3%+23.3%
Shenzhen YHLO Biotech 688575.SSChina$882M-16%+3%12%30.7×2.0%+12.7%
Bioventus BVSUnited States$895M-3%+4%10%13.0×7.5%+12.1%
Hangzhou Biotest Biotech 688767.SSChina$878M-12%-4%3%37.0×n/an/a
Xiangyu Medical 688626.SSChina$877M-38%0%4%56.2×n/an/a
Artivion AORTUnited States$905M-18%+14%5%383.6×n/an/a
Tinavi Medical Technologies 688277.SSChina$872M-36%-2%-59%n/an/an/a
Kuros Biosciences KURN.SWSwitzerland$907M-12%+41%6%70.5×n/an/a
Beijing SDL Technology 002658.SZChina$864M-34%-13%9%22.4×16.8%+2.9%
HOB Biotech 688656.SSChina$858M-33%+6%7%166.9×37.6%+12.4%
Shantou Institute of Ultrasonic Instruments 301602.SZChina$858M-25%+4%30%n/a11.1%+4.6%
Modern Dental 3600.HKHong Kong$844M+24%+12%22%8.5×-7.1%+11.3%
Cisen Pharmaceutical 603367.SSChina$843M-15%-6%8%7.9×-14.6%-1.3%
L&C BIO 290650.KSSouth Korea$943M-37%+65%20%n/a32.6%+21.0%
Cofoe Medical Technology 1187.HKHong Kong$836M-11%+40%10%13.1×-6.4%+6.6%
Menicon 7780.TJapan$944M+26%+6%9%20.9×n/an/a
Safilo SFL.MIItaly$953M+42%-4%9%15.8×1.3%+4.7%
OrthoPediatrics KIDSUnited States$826M+71%+16%-8%n/an/an/a
JINS 3046.TJapan$963M-8%+14%10%18.7×-6.1%+11.7%
Ningbo Jansen Superconducting Technologies 688805.SSChina$818M-36%+36%16%n/a35.6%+17.1%
Mani 7730.TJapan$965M-7%+10%30%19.9×3.3%+13.9%

Questions

Who are Aidite (Qinhuangdao) Technology's main competitors?
Named competitors: 3M Oral Care (MMM), Dentsply Sirona (XRAY). The cockpit's measured peer set (industry) also includes Shenzhen YHLO Biotech (688575.SS), Bioventus (BVS), Hangzhou Biotest Biotech (688767.SS), Xiangyu Medical (688626.SS), Artivion (AORT), Tinavi Medical Technologies (688277.SS).
Is Aidite (Qinhuangdao) Technology expensive compared with its peers?
On forward p/e it trades at 26.2× against a peer median of 20.9×, 7th most expensive of 16 in its peer set. For today's price to make sense, revenue must grow about 19% a year for seven years (Req g). Recent delivered growth is +23%, so the hurdle is -4 pp: the price already allows for a slowdown.
How has Aidite (Qinhuangdao) Technology stock performed?
Over six months to 18 Nov 2026 the shares returned -11.7% against -13.6% for the median peer; over one year +23.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.